Open AccessCholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis
Author(s) -
Shinji Matsunaga,
Taro Kishi,
Ichiro Yasue,
Nakao Iwata
Publication year - 2015
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyv086
Subject(s) - dementia with lewy bodies , discontinuation , dementia , lewy body , cholinesterase , medicine , adverse effect , number needed to harm , anesthesia , randomized controlled trial , psychology , relative risk , disease , confidence interval , number needed to treat
We performed a meta-analysis of cholinesterase inhibitors for patients with Lewy body disorders, such as Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom